Earnings Feed
Start Free
Home/Filings/4/0001735276-26-000015
4//SEC Filing

Garg Pushkal 4

Accession 0001735276-26-000015

CIK 0001178670other
View on SEC.govCompany Profile

Filed

Jan 13, 7:00 PM ET

Accepted

Jan 14, 4:23 PM ET

Size

44.9 KB

Accession

0001735276-26-000015

Insider Transaction Report

Form 4
Period: 2026-01-11
ALNYLAM PHARMACEUTICALS, INC.ALNY
Garg Pushkal
EVP Chief R&D
Transactions
  • Award

    Common Stock

    [F1]
    2026-01-11+3,800→ 24,021 total
  • Sale

    Common Stock

    [F2][F3]
    2026-01-12$353.95/sh−39$13,804→ 23,982 total
  • Sale

    Common Stock

    [F2][F4]
    2026-01-12$355.16/sh−42$14,917→ 23,940 total
  • Sale

    Common Stock

    [F2][F5]
    2026-01-12$356.09/sh−41$14,600→ 23,899 total
  • Sale

    Common Stock

    [F2][F6]
    2026-01-12$357.17/sh−96$34,288→ 23,803 total
  • Sale

    Common Stock

    [F2][F7]
    2026-01-12$358.18/sh−123$44,056→ 23,680 total
  • Sale

    Common Stock

    [F2][F8]
    2026-01-12$359.14/sh−85$30,527→ 23,595 total
  • Sale

    Common Stock

    [F2][F9]
    2026-01-12$360.22/sh−155$55,834→ 23,440 total
  • Sale

    Common Stock

    [F2][F10]
    2026-01-12$361.45/sh−98$35,422→ 23,342 total
  • Sale

    Common Stock

    [F2][F11]
    2026-01-12$362.38/sh−73$26,454→ 23,269 total
  • Sale

    Common Stock

    [F2][F12]
    2026-01-12$363.55/sh−47$17,087→ 23,222 total
  • Sale

    Common Stock

    [F2][F13]
    2026-01-12$364.83/sh−199$72,601→ 23,023 total
  • Sale

    Common Stock

    [F2][F14]
    2026-01-12$365.56/sh−220$80,423→ 22,803 total
  • Sale

    Common Stock

    [F2][F15]
    2026-01-12$366.41/sh−50$18,321→ 22,753 total
  • Sale

    Common Stock

    [F2][F16]
    2026-01-12$367.40/sh−41$15,063→ 22,712 total
  • Sale

    Common Stock

    [F2][F17]
    2026-01-12$368.62/sh−92$33,913→ 22,620 total
  • Sale

    Common Stock

    [F2][F18]
    2026-01-12$369.48/sh−40$14,779→ 22,580 total
  • Sale

    Common Stock

    [F2][F19]
    2026-01-12$370.87/sh−18$6,676→ 22,562 total
  • Sale

    Common Stock

    [F2][F20]
    2026-01-12$372.46/sh−3$1,117→ 22,559 total
  • Sale

    Common Stock

    [F2][F21]
    2026-01-12$374.44/sh−14$5,242→ 22,545 total
  • Sale

    Common Stock

    [F2]
    2026-01-12$375.65/sh−19$7,137→ 22,526 total
  • Sale

    Common Stock

    [F2]
    2026-01-12$377.82/sh−15$5,667→ 22,511 total
Holdings

  • Common Stock

    [F22]
    (indirect: by Managed Account)
    431

  • Common Stock

    [F23]
    (indirect: By Trust)
    250
Footnotes (23)
  • [F1]On March 1, 2024, the reporting person was granted a performance-based stock unit (PSU) under the 2018 Stock Incentive Plan. The shares subject to the PSU vest based on the achievement of three specified performance measures. The shares reported were issued to the reporting person upon vesting of forty (40) percent of the shares subject to the PSU based on the issuer publicly reporting $2.5 billion in annual net product revenue in accordance with GAAP, as determined by the People, Culture and Compensation Committee of the Issuer Board of Directors on January 11, 2026.
  • [F10]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $360.90 to $361.89. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F11]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $361.93 to $362.92. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F12]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $362.99 to $363.99. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F13]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $364.00 to $365.00. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F14]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $365.01 to $366.01. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F15]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $366.03 to $366.96. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F16]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $367.04 to $368.00. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F17]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $368.09 to $369.08. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F18]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $369.13 to $369.93. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F19]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $370.43 to $371.23. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F2]Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement to cover minimum statutory tax withholding obligations.
  • [F20]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $372.35 to $372.50. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F21]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $374.08 to $374.89. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F22]Reflects shares of ALNY common stock acquired by the Reporting Person under the issuer 401(k) plan as a result of the issuer 401(k) matching contribution program.
  • [F23]Represents shares held in trust, of which the Reporting Persons spouse is co-trustee. The Reporting Person disclaims beneficial ownership of these shares, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
  • [F3]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $353.53 to $354.41. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F4]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $354.54 to $355.53. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F5]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $356.62 to $356.61. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F6]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $356.63 to $357.63. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F7]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $357.68 to $358.68. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F8]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $358.69 to $359.66. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F9]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $359.79 to $360.79. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Signature
By: Brett Budzinski, Attorney-in-Fact For: Pushkal Garg|2026-01-14

Documents

1 file

Issuer

ALNYLAM PHARMACEUTICALS, INC.

CIK 0001178670

→
Entity typeother

Related Parties

1
  • filerCIK 0001829252

Filing Metadata

Form type
4
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 4:23 PM ET
Size
44.9 KB
View on SEC.gov